Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18
However, these do have to be prescribed and administered by a healthcare professional, and are more likely to be given to people who have lifelong conditions affecting their ability to absorb B12 or who are at higher risk of consistent deficiency
Oral Bioavailability Research Pharmacokinetic Profile Following Oral Administration: Research investigating oral BPC-157 bioavailability reveals unique pharmacokinetic characteristics: Gastric Stability: Resistance to pepsin degradation in gastric acid environment (pH 1.5-3.0) Maintained peptide integrity in simulated gastric fluid Survival through gastric emptying with detectable peptide in intestinal contents Unusual for pentadecapeptides, most of which undergo rapid gastric hydrolysis Intestinal Absorption: Evidence of intestinal mucosal absorption in preclinical models Detected in portal circulation following oral administration Bioavailability varies by species and experimental conditions Absorption mechanisms remain active research area (paracellular vs
Yes, when prescribed by a licensed physician
FDA safety concerns The FDA includes DSIP on its list of bulk drug substances with potential safety risks
TB-500 alone patients with large-area wound healing needs, post-surgical patients with significant tissue trauma, or those focused on cardiac tissue recovery after injury
J Appl Pharm Sci
US$ 28.63
US$ 23.48
US$ 26.37
US$ 20.90
US$ 26.88
US$ 27.31
US$ 27.61
US$ 28.62
US$ 25.70
US$ 25.86